Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is
overexpressed in prostate cancer. Radiolabeled small molecules that bind with high affinity …

Background The rapidly expanding clinical adaptation of prostate-specific membrane
antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has …

The introduction of prostate-specific membrane antigen (PSMA) in clinical practice has
revolutionized evaluation of biochemical recurrence of prostate cancer after curative-intent …

The objective of this study was to evaluate the safety and feasibility of 99mTc-based prostate-
specific membrane antigen (PSMA) robot-assisted–radioguided surgery to aid or improve …

Simple Summary The combination of positron emission tomography (PET)-diagnostics with
ligands binding to the prostate-specific membrane antigen (PSMA) has been a diagnostic …

Background 68Ga‐labelled prostate‐specific membrane antigen (PSMA) is a promising PET
ligand for the detection of prostate cancer. Little attention has been given to the ability of …

The prostate-specific membrane antigen (PSMA) is expressed by approximately 90% of
prostate carcinomas. The expression correlates with unfavorable prognostic factors, such as …

Importance Prostate cancer is the second leading cause of cancer deaths in US men. The
course of prostate cancer is highly variable, and timely and accurate detection of clinically …

Prostate cancer imaging has become an important diagnostic modality for tumor evaluation.
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) has been …

ABSTRACT Purpose: 68Ga-PSMA PET/CT imaging is a promising modality for the staging of
recurrent prostate cancer (PCa). Current evidence suggests limited diagnostic value of the …